Dallas, TX (PRWEB) September 21, 2013
Endometriosis is an estrogen-dependent disorder characterized by growth and appearance of endometrial cells or tissues in locations outside the uterus, which results in a series of chronic inflammatory reactions leading to scarring of tissues and adhesions of fibrous tissues in the pelvic region. Globally, the disease affects up to 10% of women. The condition is often associated with severe dysmenorrhea, chronic pelvic pain, chronic fatigue, deep dyspareunia, ovulation pain, abnormal bleeding and infertility.
The report provides an overview of the risk factors and global and historical trends for endometriosis in the 6MM. In addition, the report also includes a 10-year epidemiological forecast of the diagnosed prevalent cases of endometriosis segmented by age (in 5-year increments for women ages 15–49 years) and stages. Epidemiologists forecast that the diagnosed prevalent cases of endometriosis in the 6MM will grow from 5.66 million cases in 2012 to 5.86 million cases in 2022, at a growth rate of 3.4% over the forecast period.
Complete report is available @ http://www.rnrmarketresearch.com/epicast-report-endometriosis-epidemiology-forecast-to-2022-market-report.html .
Epidemiologists forecast an increase in the diagnosed prevalent cases of endometriosis in the 6MM, from 5.66 million prevalent cases in 2012 to 5.86 million prevalent case in 2022, at a growth rate of 3.4% over the forecast period. The US constituted the largest proportion (almost 90%) of the prevalent cases of endometriosis, with 5.24 million prevalent cases in 2022. Endometriosis is not a life-threatening condition and is largely influenced by hereditary factors. However, the condition will cause substantial economic, physical and psycho-social burden to the individual, as well as to the healthcare system, during the forecast period.
Reasons To Buy
Purchase a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=116032 .
Browse more reports on Women’s Health Therapeutics Market @ http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/womens-health-therapeutics .
Contact sales(at)rnrmarketresearch(dot)com for further information.
RnRMarketResearch.com (http://www.rnrmarketresearch.com/) is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
Read the full story at http://www.prweb.com/releases/endometriosis-market/forecast-to-2022/prweb11144952.htm.
Copyright©2012 Vocus, Inc.
All rights reserved